SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals informs about closure of trading window

01 Jul 2024 Evaluate

Pursuant to Company's Code of Conduct framed in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended, Bharat Parenterals has informed that the Trading Window for dealing in the securities of the company for all designated persons specified under the Code shall remain close form 1st July, 2024 onwards till 48 hours after the declaration of Audited Financial Results for the Financial year ended 30th June, 2024. Accordingly, all designated persons have been advised not to trade in the securities of the company during the aforesaid period of Closure of Trading window.

The above information is a part of company’s filings submitted to BSE.

Bharat Parenterals Share Price

1213.10 32.30 (2.74%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×